Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-06-13

Clinical Trial Update: Modelling of Quality Life, Clinical and Physiological Measures in Idiopathic Pulmonary Fibrosis

View source ↗

Summary

An ongoing clinical trial update describes modeling quality of life, clinical, and physiological outcomes in idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of East Anglia | Conditions: Idiopathic Pulmonary Fibrosis, Dyspnoea | Status: UNKNOWN